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Abstract
Background: Computer-based morphometry can minimize subjectivity in the assessment of liver fibrosis. An image 
processing program was developed with Delphi for the quantification of fibrosis in liver tissue samples stained with 
Sirius Red. Bile duct ligated and sham operated wild type C57BL/6 mice served as a model of time-dependent 
induction of liver fibrosis. Formation of fibrosis was determined with the developed software at day 0, 3, 7, 10, 14, 20, 30 
and 60. The results were compared to a semi-quantitative scoring system.
Results: Quantitative accumulation of collagen fibres was observed from day 3 to day 14, with a slight further increase 
thereafter. During ongoing fibrogenesis, there was a significant elevation of alanine aminotransferase (ALT), aspartate 
transaminase (AST) and bilirubin. The results from our computer-based morphometric analysis were highly correlated 
with the results that were obtained in a standardized pathology semi-quantitative scoring system (R 2 = 0.89, n = 38).
Conclusions: Using our Delphi-based image analysing software, the morphometric assessment of fibrosis is as precise 
as semi-quantitative scoring by an experienced pathologist. This program can be a valuable tool in any kind of 
experimental or clinical setting for standardized quantitative assessment of fibrosis.
Background
Liver fibrosis is characterized by an increase of collage-
nous matrix (the quantitative aspect of fibrosis). There is
also a reduction of the vascular bed, pathologic perfusion,
atrophy and regeneration of parenchyma leading to a fun-
d a m e n t a l  r e b u i l d i n g  o f  t i s s u e  a r c h i t e c t u r e  ( q u a l i t a t i v e
aspect of fibrosis). Complete organ fibrosis represents the
final course of chronic progressive liver diseases.
Pathologists describe changes in these two dimensions
subjectively or semi-quantitatively by a variety of scoring
systems depending on the underlying disease causing dif-
ferent histological patterns. For example, in chronic hep-
atitis the Ishak score [1] is used. In alcoholic or non
alcoholic steatohepatitis, fibrotic progression has been
quantified by Brunt and colleagues [2]. Cholangiode-
structive and cholangitic diseases are scored according to
Portmann and Nakanuma [3]. A computer-based mor-
phometry for the assessment of liver fibrosis is currently
not in use for standard clinical diagnostics but is some-
times used scientifically in experimental models [4-8].
The primary goal of the present study was the develop-
ment of highly user-friendly, charge-free and open source
computer software to assess the quantitative aspect of
liver fibrosis in a standardized and reproducible manner.
Therefore, we used the model of bile duct ligation (BDL)
to induct liver fibrosis in C57/BL6 mice. The experimen-
tal model has been well described and evaluated in rats
and mice [9,10] and has been widely used to study chole-
static liver injury [11,12] and fibrogenesis [9,13,14]. We
analysed time-related quantitative and semi-quantitative
aspects of murine liver fibrosis and evaluated the differ-
ent measurement techniques.
Results
Impact of bile duct ligation on survival, activity and 
jaundice
We have performed BDL in 40 animals and analysed
ongoing hepatic fibrogenesis in respective animals at
fixed time points (Figure 1). All sham-operated animals
survived but two of 40 mice in the BDL group became
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moribund and were killed before the planned end point.
The activity of sham-operated animals was nearly normal
24 h after the lapratomy while the animals subjected to
BDL showed reduced activity during the first 72 h but
regained normal activity thereafter. Jaundiced skin was
already apparent in all animals 24 h after BDL.
Hepatocellular injury and cholestasis after BDL
Alanine aminotransferase (ALT) and aspartate transami-
nase (AST) increased rapidly after BDL, peaking at 7
respectively twenty days after the surgery. After the peak-
ing, ALT and AST decreased steadily until day 30; serum
levels remained almost unchanged after 60 days. Bilirubin
levels steadily elevated and reached a plateau after 7 days.
Total protein serum levels had a greater variability with a
slight decrease after 7 days (Figure 2).
Development of liver fibrosis
The stage of fibrosis was assessed semi-quantitatively.
Periportal fibrosis was staged 0-4 and perisinusoidal
fibrosis was scored 0-2 by an experienced pathologist
(HPF), giving a maximum possible of 6 (Table 1). The
morphometric computer-based assessment of fibrosis
showed 0.13 ± 0.037% fibrosis-index in the sham oper-
ated group. A strong accumulation of collagen fibres was
observed between day 3 (0.10 ± 0.03%) and 14 (4.75 ±
0.35%), with a slight further increase thereafter (Table 2,
Figure 3). The mean fibrosis score in sham operated ani-
mals was 0.00 ± 0. It increased steadily until day 60 to
4.83 ± 0.17. The maximum of periportal fibrosis (stage 3;
complete lamellae) was reached at day 20 (3.0 ± 0.0).
Peripsinusoidal fibrosis was absent during the first 10
days and was established after 14 days (1.0 ± 0.0). It
increased steadily until day 60 to 1.8 ± 0.17 (Table 2, Fig-
ure 3).
Both the total and periportal semi-quantitative scoring
values showed a good correlation with the computer-
based assessment and could be fitted to a linear regres-
sion curve (R2 = 0.89 versus R2 = 0.86; n = 38). However,
semi-quantitative scoring of perisinusoidal fibrosis
showed a lower correlation (R2 = 0.64, n = 38) (Figure 4).
Discussion
Liver fibrosis is a major parameter guiding the diagnosis
and prognosis of chronic liver diseases and liver biopsy
and its histological evaluation remains the gold standard
for diagnosis and prognosis. Therefore, accurate qualita-
tive and quantitative assessment of fibrosis is essential.
Many scoring systems were designed to classify and stage
different chronic liver diseases [1,2,15]. One major flaw of
these scoring systems is that they are dependent on the
visual interpretation of the observer. In addition, the
observer must be an experienced pathologist. In order to
avoid these pitfalls, over the last decade quantification of
fibrosis by multiple computer assisted methods has been
introduced [5,7,16,17]. The principle behind these meth-
ods is to stain a section with a specific tissue stain that
highlights collagen fibres. Then, with the aid of the soft-
ware, the fibrotic area is calculated. Ideally, the correct
assessment of total fibrosis should be possible fully com-
puterized that rules out intra- and inter-observer varia-
tions. Dahab et al. used the commercial program Adobe
Photoshop to calculate a fibrosis index [6]. In addition,
there are different companies (Soft Imaging Systems,
Münster, Germany or Aperio, CA, USA) who sell pro-
grams which have been designed specially for image anal-
ysis purpose. These programs are usually highly
expensive and are not easily adjustable.
Therefore, we have written a new simple, charge free,
computer-based morphometric assessment tool to evalu-
ate liver fibrosis. This software (Fibromat) is written in
Delphi - one of the best known and widely used program-
m i n g  t o o l s  -  t o  c r e a t e  s o f t w a r e  a n d  a p p l i c a t i o n s  f o r
Microsoft Windows computers. With Delphi it is possible
to create small powerful applications which do not need
to be installed, do not depend on Active X controls or
special DLLS. Therefore, there are no problems with
installation, as usually observed with software from other
programming utilities (for example, Java, .NET, Visual
Basic or Visual C++). The program allows the determina-
tion of different colour intensities that are necessary
when morphometric scoring is necessary, for example,
Sirus Red stained specimen. In order to perform a quanti-
tative analysis, respective images of such a stain are first
transformed into a grey scale and then further modified
into a colour image in which the calculated background is
depicted in black, liver parenchyma in light green and
fibrous deposits in red. After this conversion, a precise
and rapid mathematical quantification (in %) of individ-
ual colours is possible.
Figure 1 Study design and experimental setting. Bile duct ligation 
was performed on day 0. Analysis was performed on day 3 and 7 after 
the procedure to measure short time effects. Time-points after 10, 14 
and 20 days were chosen to display intermediate and 30 and 60 days 
to analyse long-term effects.Huss et al. Fibrogenesis & Tissue Repair 2010, 3:10
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One major advantage of our program is that it is open
source. Therefore, the complete source code of the pro-
gram is accessibly by downloading it (T Additional file 1)
and it is easily adapted it to specific needs. For example
one can choose different colors for the morphometrical
analysis and make the program suitable for Massons Tric-
rome Staining or any immunohistochemical staining.
With little effort an analysis of different subtypes of colla-
gen is possible.
As previously mentioned, the pattern of fibrosis
depends on the aetiology, severity and duration of the
underlying disease. We investigated the qualitative and
quantitative aspects of murine liver fibrosis caused by bile
duct ligation using a semi-quantitative score. The pattern
of fibrosis caused by this procedure can be compared, to a
certain degree, to the pattern occurring in primary biliary
cirrhosis (PBC). There is a type of periportal fibrosis that,
along with the proliferation of neoductules and peri-
ductular fibrosis, leads to porto-portal septae [18]. A
semi-quantitative scoring system for PBC was first
described in 1965 by Rubin et al. [19]. They described
four successive stages, which were modified by others
[20-22] and summarized by Portmann and Nakanuma
[3]. Other work groups scored their BDL-experiments
according to one of these systems [23,24].
However, the scoring systems discussed were originally
designed to score PBC, an autoimmune liver disease with
an unknown aetiology where selectively small intrahe-
patic bile ducts are destroyed. The pathogenic mecha-
nism has to be distinguished from that occurring in BDL,
where the common bile duct is ligated. Secondary to this
procedure, small bile ducts react and form neoductuli [9].
We propose an alternative approach to assess fibrotic
changes after murine bile duct ligation with a two-tired
Figure 2 Serum markers of cholestasis and hepatocellular injury during bile duct ligation. Biochemical markers are shown for (A) bilirubin, (B) 
total protein, (C) alanine aminotransferase and (D) aspartate transaminase.Huss et al. Fibrogenesis & Tissue Repair 2010, 3:10
http://www.fibrogenesis.com/content/3/1/10
Page 4 of 8
scoring system. Modified after Portmann and Nakanuma
[3] we staged periportal fibrosis as follows: 0, no fibrosis;
stage 1, focal periportal and perineoductular fibrosis that
build incomplete lamellae around affected portal fields;
stage 2, fully established periportal and perineoductular
fibrosis building complete lamellae, with or without spo-
radic portal-portal bridging; stage 3, an extension of the
portal-portal bridging (three or more bridges per 10 por-
tal fields); and stage 4, fully developed cirrhosis (Addi-
tional File 2). However, stage 4 was not observed in our
experimental setting. This finding is different to descrip-
tions of the rat model. Here fibrosis is progressive and
cirrhosis can develop within 15 days after BDL [25]. Fur-
thermore, we staged perisinusoidal fibrosis as follows: 0,
no fibrosis; stage 1, a mild fibrosis with less than 50% of
the lobule affected; and stage 2, a severe fibrosis with
more than 50% of the lobule affected.
In our model, periportal fibrosis was fully developed
after 20 days; persinusoidal fibrosis become evident at
day 10 and increased until the end of the experiment (day
60). When semi-quantitative scoring data are evaluated,
it is important to bear in mind that the numbers repre-
sent categories rather than measurements. They, there-
f o r e ,  c a n n o t  b e  u s e d  a s  r e a l  n u m b e r s  i n  s t a t i s t i c a l
analyses [26,27]. Also adding the numbers representing
different grading components (periportal and perisinu-
soidal) together to create a total score can lead to inaccu-
racies. At best, a total grading score can give only an
approximate idea of the severity of disease [28]. We,
therefore, correlated every dimension as well as the total
score of our two-tired scoring system with the calculated
fibrotic-index. We could show that the periportal fibrosis,
as well as total score, is highly correlated but perisinusoi-
dal fibrosis is lower. These findings suggest that a qualita-
tive assessment of the computerized fibrosis pattern
might still be necessary for an accurate interpretation of
computerized fibrosis ratio, because a merely quantita-
tive fibrotic-index of a specimen does not display all the
information supplied by a visual interpretation of the
slide. Nevertheless both, the semi-quantitatively scoring
and the computer-based assessment (fibrotic-index)
showed good correlation in depicting increased collagen
deposition as a consequence of ongoing fibrogenesis.
Therefore, we propose this highly user-friendly image
analysis tool for the accurate quantification of collagen
deposits in Sirius Red stained liver sections. The image
processing is computerized and, for this reason, more
insensitive to intra- and inter-observer variations than a
semi-quantitative scoring system.
Conclusions
We designed an easy-to-use, charge free and open source
Delphi-based computer program to assess the quantita-
tive aspect of liver fibrosis in a standardized and repro-
ducible way. The program was evaluated in an
experimental setting of murine liver fibrosis following
bile duct ligation. It can also be used for the analysis of
fibrosis due to other aetiopathologies.
Methods
Animals
Male C57BL/6 mice (Harlan Laboratories, Eystrup, Ger-
many) aged 10-12 weeks were kept under controlled envi-
ronmental conditions with a 12-h light-dark cycle for a
minimum of 7 days before surgery. Mice were fed on a
standard laboratory diet with food and water ad libitum.
A l l  e x p e r i m e n t s  w e r e  a p p r o v e d  b y  t h e  L a n d e s a m t  f ü r
Natur, Umwelt und Verbraucherschutz NRW, Reckling-
hausen, Germany (AZ 50.203.2 AC20, 13/06 and AZ
8.87-50.10.37.09.248).
Procedures
BDL
After midline skin lapratomy the liver was gently
removed and the common bile duct was mobilized. In the
region above the pancreas two 4-0 nylon sutures were
Table 1: Semi-quantitative scoring of fibrosis: a two-tired scoring 
system for histopathological liver changes after murine bile duct 
ligation
Periportal fibrosis Score
No fibrosis 0
Scattered periportal and perineoductular fibrosis 
(incomplete lamellae)
1
Periportal, perineoductular fibrosis (complete lamellae) +/- 
beginning septa
2
Periportal, perineoductular fibrosis with portal-portal septa * 3
Complete cirrhosis 4
Perisinusoidal fibrosis
No fibrosis 0
Mild fibrosis (fibres in < 50% of the perisinusoidal spaces) 1
Severe fibrosis (fibres in > 50% of the perisinusoidal spaces) 2
*Three or more portal-portal septa have to be found per 10 portal 
fields.Huss et al. Fibrogenesis & Tissue Repair 2010, 3:10
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placed around the bile duct and carefully tightened to
avoid rupture.
Sham lapratomy (control)
Lapratomy and mobilization of the common bile duct
were performed as in the former group but without liga-
tion.
In order to measure short time effects of the BDL, mice
were sacrificed at day 3 and 7 after the surgery. In order to
indicate intermediate time effects mice were sacrificed
after 14 and 20 days, to assess long term effects after 30
and 60 days. Control animals were killed 20 days after the
sham lapratomy. At indicated time points, blood was
drawn from the right ventricle, centrifuged and the serum
was stored at -80°C until further analysis. The liver was
removed and fixed in 4% buffered formalin for 24 h for
histological analysis.
Measurement of serum parameters
Blood biochemical parameters (bilirubin, ALT, AST and
total protein) were measured using the Modular Pre-
Analytics (MPA) system (Roche Diagnostics, Mannheim,
Germany)
Histology
After being fixed in 4% buffered formalin for 24 h, the
liver tissue was embedded into paraffin wax. A histologi-
cal semi-quantitative examination of the liver was per-
f o r m e d  o n  s e c t i o n s  a f t e r  s t a n d a r d  S i r i u s  R e d  s t a i n i n g.
Periportal fibrosis was staged 0-4 and perisinusoidal
fibrosis was scored 0-2, giving a maximum possible of 6
(Table 1).
Development of the image analysing program
The principle behind computer-based morphometry is
the different staining pattern of cells, nuclei and fibres
following Sirius Red staining. Collagen fibres, as well as
cell nuclei, appear red, while the hepatocellular cyto-
plasm becomes pale and yellowish.
For the analysis, 10 photographs of random high-power
fields (100 × magnifications) were taken of each liver
sample. Large bile ducts and vessels were excluded. Pho-
tographs were stored as 1280 × 1024 pixel RGB-bitmaps
(bmp) with a colour-resolution of 24 bits per pixel. These
pictures were analysed with our Delphi-based program as
follows. After a shading correction, a grey transformation
- derived from the green color channel only - is calculated
from the original image. Then a blurring filter based on
an arithmetic mean filter is applied. Thresholding of the
positively stained collagen fibres is performed by a histo-
gram analysis of the grey value distribution resulting in a
binary image. As cell nuclei and fibres appear to have the
same staining intensity, binary object detection is per-
formed and all objects with an area lower than a specific
threshold are eliminated, distinguishing between fibres
and nuclei. The total area of the combined fibres is
expressed as a percentage of the total parenchyma area.
Table 2: Fibrosis index and semi-quantitative score
Time after bile duct ligation (days) Fibrosis index (%) Semi-quantitative score
Portal fibrosis Perisinusoidal fibrosis Total score
0 (n = 3) 0.13 ± 0.04 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
3 (n = 5) 0.10 ± 0.03 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
7 (n = 5) 0.76 ± 0.11 0.60 ± 0.25 0.0 ± 0.0 0.60 ± 0.25
10 (n = 5) 1.65 ± 0.22 1.40 ± 0.25 0.25 ± 0.25 1.67 ± 0.25
14 (n = 5) 4.75 ± 0.35 2.4 ± 0.25 1.0 ± 0.0 3.40 ± 0.24
20 (n = 4) 5.02 ± 0.47 3.0 ± 0.0 1.0 ± 0.0 4.0 ± 0.0
30 (n = 5) 5.45 ± 0.35 2.8 ± 0.2 1.4 ± 0.25 4.20 ± 0.20
60 (n = 6) 5.63 ± 0.25 3.0 ± 0.0 1.8 ± 0.17 4.83 ± 0.17
Fibrosis index (% Sirius Red stain) and semi-quantitative score consisting of portal fibrosis score, perisinusoidal score and total score (mean +/- 
standard error of mean; see Table 1)Huss et al. Fibrogenesis & Tissue Repair 2010, 3:10
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These steps are performed automatically and the dis-
played resulting image shows background in black, liver
parenchyma in a light green and fibrosis intense red (Fig-
ures 5 and 6). Nevertheless, the user has several options
to interact with the program, eliminate different common
errors and to simplify his work. (i) Sirius Red staining can
have different intensities due to staining time and/or
thickness of the histological slide. The user can modify
the threshold of the grey transformation to minimize
these effects. (ii) If random sections of a sample were
taken there may be flapped areas or other artifacts giving
a wrong signal. The user can exclude obviously mistaken
objects by a simple mouse click. All steps of the complete
procedure are visualized in one display and are therefore
easy to follow. (iii) Lumina of small vessels, as well as the
background, are automatically excluded from the total
area of the parenchyma. (iv) Unlimited photographs can
be analysed one after another. The user can save and
reopen the current working file or send it to a co-worker
who can proceed or reevaluate the work. (v) The values
(0.00-1.00, that is 0% to 100% fibrosis) can be exported to
a text file and re-imported into Excel, GraphPad, SPSS or
another program for statistical analysis. The software,
which is compatible with Microsoft Windows 7, Micro-
soft Vista SP2, Microsoft Windows XP Home or Profes-
sional (SP2 or SP3), can be downloaded from the journal
home page (Additional File 1). Details of programming
are available on request.
Figure 3 Semi-quantitative analysis versus computer-based mor-
phometrical analysis. (A) A semi-quantitative score that considers 
both periportal and perisinusoidal fibrosis was determined and com-
pared to (B) the morphometric analysis determined in Sirius Red 
stained specimen.
Figure 4 Correlation between semi-quantitative and computer-
based analysis. Linear regression fit between semi-quantitative total 
(A; R2 = 0.89), periportal (B; R2 = 0.86) and perisinuidal (C; R2 = 0.64) 
score and morphometric assessment (Percentage of positively stained 
surface, Sirius Red Staining; n = 38.)Huss et al. Fibrogenesis & Tissue Repair 2010, 3:10
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Statistical analysis
All results are expressed as the mean values ± standard
error of mean, except for serum parameters of the ani-
mals, which are expressed as mean values ± standard
deviations. Semi-quantitative scores were correlated with
the values from the computer assisted morphometrical
analysis using Graph Pad Prism software.
Additional material
Abbreviations
ALT: alanine aminotransferase; AST: aspartate transaminase; BDL: bile duct liga-
tion; bmp: bitmaps; PBC: primary biliary cirrhosis.
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Additional file 1 The Fibromat, an open source Delphi-based soft-
ware for computer-based morphometry. Download the file and unzip it 
to your hard disc. Open Delphi (installation is required; program can be 
obtained from Borland, Texas, USA). Open the file 'ihc.exe' and start the pro-
gram. If you have any questions on how to use or modify the program feel 
free to contact us via the corresponding author.
Additional file 2 Scoring periportal fibrosis. (A) A normal portal field 
without fibrosis (stage 0). (B) Focal periportal and perineoductular fibrosis 
(incomplete lamellae, stage 1). (C) Fully established periportal and perineo-
ductular fibrosis building complete lamellae, with or without sporadic por-
tal-portal bridging (stage 2). (D) Extension of the portal-portal bridging 
(three or more bridges per 10 portal fields, stage 3); complete cirrhosis 
(stage 4) is not shown.
Figure 5 Computer-based morphometry. (A) Photograph of a Sirius 
Red stain of a liver section (100 × magnifications). (B) Grey transforma-
tion, blurring and shading of respective photograph. (C) Resulting im-
age of respective photograph. Background is black, liver parenchyma 
light green and fibrosis intuitively red.
Figure 6 Screenshot of program interface. The original photo-
graphs are shown in the upper left corner. In the upper right corner the 
same picture is shown after adding the grey transformation, blurring 
and shading. The histogram analysis is shown in the lower right corner. 
The image in the lower middle shows the calculated background in 
black, the liver parenchyma in a light green and fibrosis intuitively red. 
The percentage of fibrous tissue is calculated on the lower left side 
(black arrow).Huss et al. Fibrogenesis & Tissue Repair 2010, 3:10
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